1
/
of
1
NANO - GLP1 -R3Ta – 30mg + 3ml BAC Water
NANO - GLP1 -R3Ta – 30mg + 3ml BAC Water
Regular price
R 1,500.00 ZAR
Regular price
Sale price
R 1,500.00 ZAR
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Metabolic Research Compound
Retatrutide is an investigational triple-receptor agonist peptide (targets GLP-1, GIP, and glucagon receptors) under development for obesity and type 2 diabetes. Phase 2 trials demonstrated remarkable weight-loss efficacy, with patients losing up to 24% of body weight at 48 weeks on higher doses.
Research use
| Volume mg/vial | 30 |
| Typical range | 0.5–12 mg once weekly |
| How Frequent | Once weekly (Same day) |
| Injection Timing | Morning, fasted |
| Total Cycle length | 24–28+ weeks |
| Injection Route | Subcutaneous injection |
| Lyophilised: | −20 °C |
| Reconstituted: | 2–8 °C; |
| Use within | 4 weeks |
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- ~1.667 mg/mL (1667 mcg/mL) concentration. 1 unit = 0.01 mL ≈ 16.67 mcg on a U‑100 insulin syringe.
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Share
